Background: Pharmacologic treatment options for borderline personality disorder (BPD) remain limited, and no medication has received regulatory approval for its treatment. Given the high rates of comorbid depression and suicidal ideation in BPD, there is growing interest in novel therapeutic approaches. Ketamine has been approved for treatment-resistant depression and acute suicidality, raising...
Mindfulness has become a popular term in the 21st-century zeitgeist. Researchers have attempted to establish that anyone can reap benefits from practicing mindfulness, ranging from healthcare professionals (HCPs) and business executives to patients experiencing florid psychosis. Given the abundance of research on mindfulness-based intervention, it would be prudent for HCPs to understand the...